Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Alisertib by Puma Biotechnology for Metastatic Breast Cancer: Likelihood of Approval
Alisertib is under clinical development by Puma Biotechnology and currently in Phase II for Metastatic Breast Cancer. According to GlobalData,...
Data Insights
Alisertib by Puma Biotechnology for Small-Cell Lung Cancer: Likelihood of Approval
Alisertib is under clinical development by Puma Biotechnology and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData,...